Arrayit specializes in advanced microarray technology, which significantly enhances the capabilities of scientific research across various fields, including genomics and proteomics. Their microarray products enable researchers to miniaturize traditional laboratory tests by a factor of 100 or more, leading to reduced costs and increased throughput. This technology is instrumental in identifying biomarkers and deciphering complex biological pathways related to diseases such as Parkinson's and ovarian cancer. Arrayit's microarrays have been featured in over 6,000 peer-reviewed publications, underscoring their credibility and impact in the scientific community.

The company offers a comprehensive suite of microarray-based products and services, including DNA and protein microarrays, microarray manufacturing robots, and specialized software for data analysis and design. Arrayit's patented microarray printing technology has set the industry standard since 1997, allowing for the creation of diverse microarray content. Their offerings also include cleanroom products, labeling kits, and high-performance substrates, all designed to facilitate cutting-edge research and diagnostic applications. By providing these innovative tools, Arrayit empowers scientists to make significant discoveries that can lead to transformative advancements in healthcare.

United States

Arrayit develops, manufactures, and markets life science tools and integrated systems for the analysis of genetic variation and biological function.

Arrayit

Company Details